An ACT Government Website
 Back

Commentary

Five-year relative survival for melanoma has not changed significantly over time, from 91.4% in the period 1988–1997 to 90.3% for the period 2008–2017. While there were no significant differences in survival for males and females, people aged 0–64 years had better survival (95%) than those aged 65 and over (84%). Despite the 90% 5-year relative survival, the disease remains a significant health problem for the ACT community. The treatment of advanced stage melanoma has recently improved dramatically and may further improve relative survival rates in years to come.1-8

Chart

ACT Cancer survival by period, lung cancer, persons

Data

To access the data, select "View source data" link at the bottom of the visualisation. This link will open up a data table that you can download.

Codes and sources

Source: ACT Cancer Registry

This page is managed by: ACT Health Directorate